NOA 2023: Identifying eyelid conjunctiva growths and degenerations
Pierce Kenworthy, OD, met with Optometry Times to talk about his course titled, "Eyelid Conjunctive Growths & Degenerations: From Benign to Terrifying," which he will be presenting at the National Optometric Association 2023 annual convention in Fort Lauderdale, Florida.
AOA 2023: Treating photophobia
Jacqueline Theis, OD, FAAO, discusses photophobia and how to most effectively treat this patient population, including when and how to utilizing blue light blockers.
AOA 2023: Diving into new data on MiSight contact lenses for myopia management
At AOA Optometry's Meeting 2023, in Washington, DC, Justin Kwan, OD, FAAO, provides updates on the latest at CooperVision, including new data on MiSight myopia management contact lenses and information on their ortho-K software, Visavy.
AOA 2023: Stay current with the updated AMD landscape
Mohammad Rafieetary, OD, FAAO, shares brief highlights from his 2023 AOA presentation, "AMD updates: Staying current with its landscape," which he co-presented with Jay Haynie, OD, FAAO.
AOA 2023: Reviewing the anatomy, pathophysiology of eye pain and its role in dry eye
Jacqueline Theis, OD, FAAO, shares insights from her AOA 2023 presentation on treating neurologic dry eye.
AOA 2023: Eyechiatry: The psychology of vision loss
Mohammad Rafieetary, OD, FAAO, shares brief highlights from his 2023 AOA presentation, "Do you practice Eyechiatry? The psychology of vision loss," which he co-presented with Roya Attar, OD, MBA.
AOA 2023: Take a look into white dot syndrome
Roya Attar, OD, discussed, "White dot syndrome: More common than you think," which she will be presenting at AOA 2023 in Washington, DC.
AOA 2023: Preparing to conquer keratoconus management in clinical practice
Melissa Barnett, OD, FAAO, FSLS, FBCLA, shares insights from her AOA 2023 presentation on managing keratoconus in clinical practice.
AOA 2023: Pooled analysis of Gobi and Mojave studies for NOV03 treatment of MGD
Ahmad M. Fahmy, OD, FAAO, Dipl ABO, gives highlights of his AOA 2023 poster that was a pooled analysis of the Gobi and Mojave studies relevant to perfluorohexyloctane (NOV03) for dry eye disease associated with Meibomian gland dysfunction.
A peek into the history of the International Keratoconus Academy
Andrew Morgenstern, OD, FAAO, FNAP, gives a brief history of the International Keratoconus Academy of Eye Care Professionals.
AOA 2023: 12 new treatments optometrists should know about
Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation, which covered 12 new treatments all optometrists should know about.
AOA 2023: Surgical interventions should be considered earlier in glaucoma treatment
Justin Schweitzer, OD, FAAO, and Nathan Lighthizer, OD, provide key takeaways from their 2023 AOA presentation, "Beyond drops: Surgical considerations in glaucoma," which they will give alongside Walter Whitley, OD, MBA, FAAO.
AOA 2023: Push for diversity, equity, and inclusion in optometry
Charissa Lee discusses diversity, equity, and inclusion within her role at Johnson & Johnson Vision and in the industry overall.
AOA 2023: Pharmaceutical treatment of anterior segment inflammatory conditions
Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation that discussed the pharmaceutical treatment of anterior segment inflammatory conditions.
AOA 2023: Clinical study gives AMD patients possible new treatment
Jeffry Gerson, OD, FAAO, who presented a poster on the Light Site 3 clinical study at the AOA online e-poster event, discusses a promising new treatment for patients with AMD.